The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 30, 2026 | Cobourn Steven P. | Chief Financial Officer | Grant(A) | 15K | — | $0 |
| Jan 30, 2026 | Guha Udayan | Chief Medical Officer | Grant(A) | 15K | — | $0 |
| Jan 30, 2026 | Mayer Timothy | Chief Operating Officer | Grant(A) | 15K | — | $0 |
| Jan 30, 2026 | Kundu Sourav | Sr VP, Dev. & Mfg. | Grant(A) | 8K | — | $0 |
| Jan 30, 2026 | Richman Michael | President & CEO, Director | Grant(A) | 38K | — | $0 |
| Jan 30, 2026 | Shaw Kevin G. | Sr VP, General Counsel | Grant(A) | 8K | — | $0 |
| Jun 20, 2025 | Feigal Ellen | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2025 | Webster Stephen W | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2025 | Borgman Anne Elizabeth | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2025 | Kabakoff David S | Director | Grant(A) | 28K | — | $0 |
| Jun 20, 2025 | Jones Elaine V | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2025 | Houston John G | Director | Grant(A) | 19K | — | $0 |
| Jan 31, 2025 | Richman Michael | President & CEO, Director | Grant(A) | 306K | — | $0 |
| Jan 31, 2025 | Cobourn Steven P. | Chief Financial Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2025 | Kundu Sourav | Sr VP, Dev. & Mfg. | Grant(A) | 66K | — | $0 |
| Jan 31, 2025 | Langermann Sol | Chief Scientific Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2025 | Mayer Timothy | Chief Operating Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2025 | Shaw Kevin G. | Sr VP, General Counsel | Grant(A) | 66K | — | $0 |
| Jun 20, 2024 | Borgman Anne Elizabeth | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2024 | Feigal Ellen | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2024 | Houston John G | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2024 | Jones Elaine V | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2024 | Kabakoff David S | Director | Grant(A) | 28K | — | $0 |
| Jun 20, 2024 | Webster Stephen W | Director | Grant(A) | 19K | — | $0 |
| Mar 29, 2024 | Cobourn Steven P. | Chief Financial Officer | Grant(A) | 94K | — | $0 |
| Mar 29, 2024 | Kundu Sourav | Sr VP, Dev. & Mfg. | Grant(A) | 53K | — | $0 |
| Mar 29, 2024 | Langermann Sol | Chief Scientific Officer | Grant(A) | 94K | — | $0 |
| Mar 29, 2024 | Mayer Timothy | Chief Operating Officer | Grant(A) | 94K | — | $0 |
| Mar 29, 2024 | Myint Han | Chief Medical Officer | Grant(A) | 94K | — | $0 |
| Mar 29, 2024 | Richman Michael | President & CEO, Director | Grant(A) | 244K | — | $0 |
| Mar 29, 2024 | Shaw Kevin G. | Sr VP, General Counsel | Grant(A) | 94K | — | $0 |
| Jan 31, 2024 | Cobourn Steven P. | Chief Financial Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2024 | Kundu Sourav | Sr VP, Dev. & Mfg. | Grant(A) | 66K | — | $0 |
| Jan 31, 2024 | Langermann Sol | Chief Scientific Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2024 | Mayer Timothy | Chief Operating Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2024 | Myint Han | Chief Medical Officer | Grant(A) | 117K | — | $0 |
| Jan 31, 2024 | Richman Michael | President & CEO, Director | Grant(A) | 306K | — | $0 |
| Jan 31, 2024 | Shaw Kevin G. | Sr VP, General Counsel | Grant(A) | 66K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).